Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NanoMosaic Inc. logo — Next generation proteomics and multi-omics powered by nanone...

NanoMosaic Inc.

Next generation proteomics and multi-omics powered by nanoneedles

Founded 2018 United States Waltham, United States 15 employees Series A Total: $40.75M Biopharma, Biotechnology +2

General Information

Company Name NanoMosaic Inc.
Founded Year 2018
Location United States Waltham, United States
Employees 15
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series A
Business Model B2B, Platform, SaaS
Revenue Model Subscription, Service Fee, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with NanoMosaic Inc.. To contact NanoMosaic Inc., visit nanomosaicllc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NanoMosaic Inc. compare?

A PDF of NanoMosaic Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NanoMosaic Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NanoMosaic Inc.

NanoMosaic Inc., founded in 2018, is a pioneering company in the Biopharma and Biotechnology sectors, with its headquarters in the United States. The company specializes in next-generation proteomics and multi-omics, utilizing their unique nanoneedle technology to advance early disease detection, prognostic monitoring, and biomarker discovery on a single chip.

With the slogan "Next generation proteomics and multi-omics powered by nanoneedles," NanoMosaic propels significant strides in Health Care and Health and Wellness. Its innovative approach has attracted substantial investor attention, highlighted by its latest $40.75M Series A investment, received on 06 December 2021. Esteemed investors include Insight Partners, Pura Vida Investments, RA Capital Management, Time BioVentures, and TigerGene.

NanoMosaic stands out for its groundbreaking technology, offering immense potential for revolutionizing disease diagnostics and expanding the market for personalized medication solutions.

Business keywords: proteomics, multi-omics, nanoneedles, protein interrogation, early disease detection, prognostic monitoring, biomarker discovery, single chip solutions, nano-technology, disease diagnostics, health technology, precision medicine, diagnostic innovation

Services & Products

Ultra-sensitive precision measurement of biomolecules
Multiomics diagnostics
Gene therapy manufacturing support
AAV analytics enhancement

Target Customers

Biotechnology companies Gene therapy developers Clinical research organizations Pharmaceutical manufacturers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $40.75M 5
Insight Partners Pura Vida Investments RA Capital Management
Insight Partners, Pura Vida Investments +3
06 Dec 2021

NanoMosaic Inc. Alternatives & Competitors

View All Alternatives
NanoMosaic Inc. vs
Apton Biosystems
Apton Biosystems

Innovative optical system for superior sequencing and protein detection, enabling early disease dete...

Series A
11-50 employees
Biotechnology, Health Care
NanoMosaic Inc. vs
PrognomiQ Inc
PrognomiQ Inc United States

Transform healthcare and early disease detection through the power of multi-omics data.

44 employees
Biopharma, Biotechnology
NanoMosaic Inc. vs
ArcanaBio
ArcanaBio Denmark

Everyday monitoring of health using biophotonics and AI

6 employees
Biotechnology, Health Care
View all alternatives

FAQ About NanoMosaic Inc.

Next generation proteomics and multi-omics powered by nanoneedles
NanoMosaic Inc. was founded in 2018.
NanoMosaic Inc. is headquartered in Waltham, United States.
NanoMosaic Inc. operates in Biopharma, Biotechnology, Health Care and Health and Wellness. Its work centres on proteomics, multi-omics, nanoneedles and protein interrogation. Its customers include Biotechnology companies, Gene therapy developers and Clinical research organizations.
NanoMosaic Inc. has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Service Fee and Product Sales.
NanoMosaic Inc. has approximately 15 employees.
NanoMosaic Inc. has completed 1 funding round, raising a total of $40.75M. The latest funding stage is Series A.
NanoMosaic Inc. offers: Ultra-sensitive precision measurement of biomolecules, Multiomics diagnostics, Gene therapy manufacturing support, AAV analytics enhancement.
Top alternatives and competitors to NanoMosaic Inc. include Apton Biosystems, PrognomiQ Inc, ArcanaBio, Predicine, Geneseeq Technology Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NanoMosaic Inc. and Apton Biosystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NanoMosaic Inc., https://bouncewatch.com/company/nanomosaic, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes